IRON PATH CAPITAL, L.P.
IRON PATH CAPITAL, L.P. is a Series C+ and buyout fund in the US investing in Healthcare, specialty-industrials, specialty-chemicals, life-science and clinics-outpatient-services.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, specialty-industrials, specialty-chemicals, life-science, clinics-outpatient-services
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2021
- Assets under management
- $698.5M
- Website
- ironpathcapital.com
Check size not disclosed
Thesis
Iron Path Capital, L.P. is a private equity firm founded in 2021, specializing in control investments within the lower-middle market, primarily in the healthcare and specialty industrial sectors across North America. The firm targets companies with EBITDA between $5 million and $15 million, seeking those with stable cash flows, strong management, defensible business models, and growth potential through organic expansion or consolidation. Their strategy, termed "Full Immersion Operations" (FIOps™), leverages deep sector expertise and a repeatable operating playbook to build institutional-scale companies, often focusing on businesses undergoing generational transitions or requiring operational transformation. The firm's inaugural fund closed with $273 million in commitments, and as of December 31, 2025, they managed approximately $698.5 million in AUM.
Common questions
Does IRON PATH CAPITAL, L.P. invest at the Series C+ stage?
Yes. IRON PATH CAPITAL, L.P. lists Series C+ and buyout among the stages it invests in.
Where does IRON PATH CAPITAL, L.P. invest?
IRON PATH CAPITAL, L.P. invests in the US.